Loss of GLP-2R signaling in Glp2r−/− mice increases the long-term severity of graft versus host disease
Background: Glucagon-like peptide-2 (GLP-2) reduces systemic and gut inflammation while preserving mucosal integrity. Preclinical and clinical reports implicate GLP-2 receptor (GLP-2R) agonism as a potential therapy for graft vs. host disease (GvHD). Methods: Here we assessed whether enhanced vs. lo...
Furkejuvvon:
| Váldodahkkit: | , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2026-01-01
|
| Ráidu: | Molecular Metabolism |
| Fáttát: | |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S2212877825002182 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|